Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal bupivacaine irrigation for postoperative pain after laparoscopic cholecystectomy
IRCT20221212056794N1Phase 2Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of bupivacaine in cholelithiasis and gallbladder disease (2 arms), sponsored by Yasouj University of Medical Sciences. Primary endpoint: Postoperative pain intensity. Started Dec 2022; status: completed.
02
Drugs
bupivacaine
03
Conditions
cholelithiasisgallbladder disease
Beyond the preview
Go deeper on IRCT20221212056794N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221212056794N1.